Pregnancy-related complications and risk of postpartum readmission for seizures and epilepsy: A national study

Gabriela B Tantillo1, Nathalie Jetté1,2, Ji Yeoun Yoo1

  • 1Department of Neurology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Epilepsia
|August 14, 2020
PubMed

Insights

Postpartum seizures are rare but serious. Eclampsia is the most common cause of readmission, highlighting the need for early identification and close monitoring of high-risk pregnancies to prevent complications.

Area of Science:

  • Obstetrics and Gynecology
  • Neurology
  • Public Health

Background:

  • Peripartum seizures contribute significantly to maternal morbidity and mortality globally.
  • Identifying individuals at high risk for postpartum seizures is crucial for effective management.

Purpose of the Study:

  • To determine the rate of postpartum seizure/epilepsy readmissions.
  • To identify demographic, medical, and pregnancy-related risk factors associated with these readmissions.

Main Methods:

  • Retrospective cohort study using the Nationwide Readmissions Database (2013).
  • Identified index delivery admissions and 30-day readmissions for seizures/epilepsy using ICD-9-CM codes.
  • Logistic regression analysis was employed to identify risk factors.

Main Results:

  • The 30-day readmission rate for seizures/epilepsy was 19.69 per 100,000 deliveries.
  • Eclampsia accounted for 80% of seizure/epilepsy readmissions.
  • Risk factors included eclampsia (OR=19.9), pre-existing epilepsy (OR=10.63), pre-eclampsia (OR=3.23), and gestational hypertension (OR=2.78). Higher income was associated with lower readmission odds.

Conclusions:

  • Postpartum seizure readmissions, though infrequent, are critical to prevent due to associated morbidity and mortality.
  • Eclampsia is the predominant diagnosis for postpartum seizure readmissions.
  • Early identification and close monitoring of women with pre-eclampsia and eclampsia are vital for preventing postpartum seizures.
Abstract

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.0K
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.1K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.9K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
497
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.1K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
1.4K